Reaction Details Report a problem with these data
Target
Arginase-1
Ligand
BDBM290399
Substrate
n/a
Meas. Tech.
Inhibition Assay
IC50
2000±n/a nM
Citation
 Van Zandt, M; Jagdmann, GE Arginase inhibitors as therapeutics US Patent  US10603330 Publication Date 3/31/2020 
Target
Name:
Arginase-1
Synonyms:
ARG1 | ARGI1_HUMAN | Liver-type arginase | Type I arginase
Type:
PROTEIN
Mol. Mass.:
34737.53
Organism:
Homo sapiens (Human)
Description:
ChEMBL_978893
Residue:
322
Sequence:
MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK
  
Inhibitor
Name:
BDBM290399
Synonyms:
(3R,4S)-4-(3-boronopropyl)-3-(methylamino)pyrrolidine-3- carboxylic acid | US10098902, Example 35 | US10603330, Example 35 | US11389464, Example 35
Type:
Small organic molecule
Emp. Form.:
C9H19BN2O4
Mol. Mass.:
230.069
SMILES:
CN[C@]1(CNC[C@@H]1CCCB(O)O)C(O)=O |r|
Structure:
Search PDB for entries with ligand similarity: